Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Suven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed the copies of the newspaper advertisements pertaining to Notice of Company Petition in the matter of Composite Scheme of Arrangement as mentioned therein. The advertisements as appeared today i.e. November 07, 2019 in Business Standard and Nava Telangana (Telugu).
07-11-2019
Bigul

Suven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In continuation to our letter dated November 06, 2019 regarding to Notice of Board Meeting, please find enclosed the copies of the newspaper advertisements as appeared today i.e. November 07, 2019 in Business Standard and Andhra Prabha (Telugu).
07-11-2019
Bigul

Suven Life Sciences Ltd - 530239 - Board Meeting Intimation for Intimation Of Board Meeting To Consider And Approve The Un-Audited Financial Results (Standalone And Consolidated) Of The Company Under Ind AS For The Quarter And Half-Year Ended 30 September, 2019

 SUVEN LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve With reference to above subject, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that a Meeting of the Board of Directors of the Company will be held on Thursday, the 14th November, 2019 at 11:30 a.m. at the Registered Office of the Company at SDE Serene Chambers, 6th Floor, Road No 5, Banjara Hills, Hyderabad-500034, to consider, among other things, inter alia, and take on record the following matter(s): To consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the quarter and half-year ended 30 September, 2019 and related matters. Please further note that TRADING WINDOW for dealing in the securities of the company is already closed from 01st October, 2019 as per PIT Code of the Company. Trading window will be opened from 18th November, 2019
06-11-2019
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Credit Rating

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to intimate you that the CRISIL has assigned the following ratings to the Bank facilities of our Company vide its letter dated October 15, 2019.
16-10-2019
Bigul

Suven Life Sciences Ltd - 530239 - Statement Of Investor Complaints For The Quarter Ended September 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 230320 Name of the Signatory :- K HANUMANTHA RAODesignation :- Company Secretary and Compliance Officer
16-10-2019
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Shareholding for the Period Ended September 30, 2019

 Suven Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here
11-10-2019
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Submission Of Compliance Certificate For The Half-Year Ended 30Th September, 2019

 Please find enclosed compliance certificate for the half-year ended 30th September, 2019 duly signed by the Compliance Officer and authorised representative of the share transfer agent (Karvy Fintech Private Limited, Hyderabad), under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
11-10-2019
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Compliance Certificate Under Regulation 40(10) For The Half-Year Ended 30Th September, 2019

 Please find enclosed Compliance Certificate for the half-year ended 30th September, 2019 issued by the Practising Company Secretary, under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
11-10-2019
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Closure of Trading Window

 We wish to inform you that the "Trading Window" for dealing in the securities of the Company will be closed for the Designated Persons, their immediate relatives and covered under the said Code of the Company from 1st October, 2019 and the same will remain closed till 48 hours after the declaration of Financial Results for the second quarter and half-year ending 30th September, 2019, to the public, in terms of the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
30-09-2019
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Please find enclosed Press Release of our company titled 'First Patient randomized in a Phase 2A, Proof of Concept (PoC) clinical trial of SUVN-G3031 for the treatment of Narcolepsy associated with or without Cataplexy in USA.'
24-09-2019
Next Page
Close

Let's Open Free Demat Account